Baxter Price to Sales Ratio 2010-2025 | BAX
Historical PS ratio values for Baxter (BAX) over the last 10 years. The current P/S ratio for Baxter as of June 10, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Baxter P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-06-10 | 31.72 | 1.51 | |
| 2025-03-31 | 34.04 | $21.06 | 1.62 |
| 2024-12-31 | 28.86 | $20.83 | 1.39 |
| 2024-09-30 | 37.39 | $18.69 | 2.00 |
| 2024-06-30 | 32.68 | $18.53 | 1.76 |
| 2024-03-31 | 41.40 | $18.38 | 2.25 |
| 2023-12-31 | 37.19 | $20.45 | 1.82 |
| 2023-09-30 | 36.01 | $17.70 | 2.04 |
| 2023-06-30 | 43.17 | $19.75 | 2.19 |
| 2023-03-31 | 38.16 | $19.50 | 1.96 |
| 2022-12-31 | 47.62 | $19.83 | 2.40 |
| 2022-09-30 | 50.06 | $27.18 | 1.84 |
| 2022-06-30 | 59.40 | $26.39 | 2.25 |
| 2022-03-31 | 71.42 | $25.41 | 2.81 |
| 2021-12-31 | 78.81 | $23.89 | 3.30 |
| 2021-09-30 | 73.57 | $24.38 | 3.02 |
| 2021-06-30 | 73.37 | $23.74 | 3.09 |
| 2021-03-31 | 76.60 | $22.91 | 3.34 |
| 2020-12-31 | 72.65 | $22.58 | 3.22 |
| 2020-09-30 | 72.58 | $22.28 | 3.26 |
| 2020-06-30 | 77.49 | $22.03 | 3.52 |
| 2020-03-31 | 72.87 | $22.23 | 3.28 |
| 2019-12-31 | 74.86 | $21.85 | 3.43 |
| 2019-09-30 | 78.10 | $21.16 | 3.69 |
| 2019-06-30 | 72.94 | $20.73 | 3.52 |
| 2019-03-31 | 72.21 | $20.47 | 3.53 |
| 2018-12-31 | 58.30 | $20.27 | 2.88 |
| 2018-09-30 | 68.10 | $20.15 | 3.38 |
| 2018-06-30 | 65.06 | $19.95 | 3.26 |
| 2018-03-31 | 57.15 | $19.45 | 2.94 |
| 2017-12-31 | 56.67 | $19.09 | 2.97 |
| 2017-09-30 | 54.88 | $18.85 | 2.91 |
| 2017-06-30 | 52.81 | $18.63 | 2.83 |
| 2017-03-31 | 45.11 | $18.61 | 2.42 |
| 2016-12-31 | 38.47 | $18.42 | 2.09 |
| 2016-09-30 | 41.18 | $18.35 | 2.24 |
| 2016-06-30 | 39.01 | $18.24 | 2.14 |
| 2016-03-31 | 35.34 | $18.07 | 1.96 |
| 2015-12-31 | 32.72 | $18.16 | 1.80 |
| 2015-09-30 | 28.09 | $18.52 | 1.52 |
| 2015-06-30 | 32.38 | $18.94 | 1.71 |
| 2015-03-31 | 31.72 | $22.02 | 1.44 |
| 2014-12-31 | 33.94 | $24.65 | 1.38 |
| 2014-09-30 | 33.23 | $27.44 | 1.21 |
| 2014-06-30 | 33.48 | $29.25 | 1.14 |
| 2014-03-31 | 34.07 | $28.35 | 1.20 |
| 2013-12-31 | 32.20 | $27.59 | 1.17 |
| 2013-09-30 | 30.42 | $25.99 | 1.17 |
| 2013-06-30 | 32.07 | $25.53 | 1.26 |
| 2013-03-31 | 33.63 | $25.31 | 1.33 |
| 2012-12-31 | 30.87 | $25.07 | 1.23 |
| 2012-09-30 | 27.91 | $25.05 | 1.11 |
| 2012-06-30 | 24.61 | $24.84 | 0.99 |
| 2012-03-31 | 27.68 | $24.53 | 1.13 |
| 2011-12-31 | 22.91 | $24.17 | 0.95 |
| 2011-09-30 | 25.99 | $23.78 | 1.09 |
| 2011-06-30 | 27.64 | $23.18 | 1.19 |
| 2011-03-31 | 24.90 | $22.39 | 1.11 |
| 2010-12-31 | 23.44 | $21.60 | 1.08 |
| 2010-09-30 | 22.09 | $21.36 | 1.03 |
| 2010-06-30 | 18.82 | $21.01 | 0.90 |
| 2010-03-31 | 26.95 | $20.76 | 1.30 |
| 2009-12-31 | 27.17 | $20.44 | 1.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.831B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
| Boston Scientific (BSX) | United States | $148.004B | 37.05 |
| Stryker (SYK) | United States | $145.912B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
| Medtronic (MDT) | Ireland | $112.158B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
| ResMed (RMD) | United States | $36.801B | 27.64 |
| Agilent Technologies (A) | United States | $33.162B | 21.62 |
| GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
| Terumo (TRUMY) | Japan | $26.665B | 34.63 |
| Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
| Insulet (PODD) | United States | $21.511B | 84.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
| Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
| Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.442B | 15.68 |
| ICU Medical (ICUI) | United States | $3.353B | 24.73 |
| Envista Holdings (NVST) | United States | $3.224B | 26.79 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
| LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
| AtriCure (ATRC) | United States | $1.692B | 0.00 |
| Acuren (TIC) | United States | $1.348B | 0.00 |
| Neogen (NEOG) | United States | $1.198B | 15.33 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
| Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.413B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
| Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.89 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.05 |
| Quanterix (QTRX) | United States | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
| Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.43 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |